Clinical Trial Info

Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19

Authored by
Staff

The objective of this Phase 2 study is to evaluate the efficacy of oral favipiravir plus standard of care treatment (SOC) compared with placebo plus SOC in reducing the duration of shedding of SARS-CoV2 virus in patients with mild or asymptomatic COVID-19.